No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
93 |
4. Check minimum number of eventsNone |
93 |
5. Include endpointsNone |
93 |
6. Filter based on genotype QC (FinnGen only) |
93 |
Control definitions (FinnGen only)
- Control exclude
- O15_OEDEM_PROTUR_HYPERT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF10
- Parent code in ICD-10
- O10-O16
- Name in latin
- Eclampsia
Similar endpoints
↥List of similar endpoints to
Eclampsia
based on the number of shared cases.
Similar with more cases:
- Pre-eclampsia or eclampsia
- Pre-eclampsia or poor fetal growth
- Pregnancy hypertension
- Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
- Delivery, wide proxy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 602 | 602 | - |
| Only index persons | 597 | 597 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | - |
| Only index persons | 0.02 | 0.02 | - |
| Median age at first event (years) | |||
| Whole population | - | 28.59 | - |
| Only index persons | - | 28.56 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 93 | 93 | - |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | - |
| Median age at first event (years) | 29.23 | 29.23 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 85
- Matched controls
- 848
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O15.0
ICD-10 Finland
Eclampsia in pregnancy
+∞
31.2
28
*
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
+∞
28.8
26
*
6426A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]
+∞
17.3
16
*
O15.1
ICD-10 Finland
Eclampsia in labour
+∞
16.1
15
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
+∞
13.9
13
*
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
+∞
11.7
11
*
6426B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , SYNNYTYKSEN AIKANA]
+∞
11.7
11
*
O15.2
ICD-10 Finland
Eclampsia in the puerperium
+∞
10.6
10
*
O14.1
ICD-10 Finland
Severe pre-eclampsia
+∞
10.6
10
*
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
45.9
10.3
12
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
4.7
8.6
34
106
C07AG01
ATC
labetalol; systemic
+∞
8.5
8
*
8811
FHL
Cesarean section
7.6
7.4
17
27
6462A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension
+∞
7.4
7
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
4.7
6.9
24
65
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
33
131
3.35
6.73
1.4
1.5
titre
222.9
629.1
—
7
33
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
52
283
2.90
5.97
8.4
5.2
mmol/l
1.2
1.2
0.74
43
252
(3020682) Albumin/Creatinine [Ratio] in Urine
33
141
3.08
5.86
5.8
3.5
mg/mmol
22.2
5.4
0.51
25
80
(3003458) Phosphate [Moles/volume] in Serum or Plasma
18
55
3.82
5.35
9.7
4.3
mmol/l
1.0
1.0
0.07
18
48
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
162
2.86
5.32
2.2
1.8
mg/l
1.7
0.7
1.76
29
128
(3023368) Bacteria identified in Blood by Culture
29
128
2.84
4.75
3.0
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
177
2.57
4.36
1.4
1.3
iu/ml
12.1
27.0
—
7
67
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
362
2.48
4.33
4.5
3.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
34
170
2.58
4.33
4.9
3.0
ph
7.4
7.4
—
6
23
(3012516) Albumin [Mass/volume] in Urine
29
136
2.65
4.18
5.1
2.9
mg/l
1791.9
641.4
0.28
23
78
(3022948) Iron [Moles/volume] in Serum or Plasma
22
91
2.86
4.01
3.8
2.0
umol/l
13.8
15.1
0.34
22
86
(3004789) Transferrin [Mass/volume] in Serum or Plasma
21
86
2.86
3.89
3.7
1.8
g/l
2.5
2.5
0.09
21
79
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
36
196
2.37
3.74
1.9
2.5
ng/l
7.8
16.7
4.17
15
85
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
23
103
2.64
3.59
2.0
3.3
ng/l
10.7
39.7
1.10
12
48
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
178
2.32
3.46
1.5
1.2
u/ml
1.7
9.1
1.48
20
82
(3026008) Bacteria identified in Urine by Culture
35
198
2.23
3.26
2.9
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
55
376
2.13
3.13
5.6
6.0
e9/l
0.5
0.5
0.44
50
338
(3032080) INR in Blood by Coagulation assay
33
185
2.21
3.12
2.5
3.9
inr
1.0
1.0
0.52
15
66
(3006315) Basophils [#/volume] in Blood
55
377
2.12
3.10
5.6
6.0
e9/l
0.0
0.0
0.33
50
337
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
12
6.21
3.08
1.6
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
5
10.46
3.01
1.0
1.8
umol/l
11.4
10.4
—
5
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
17
5.04
2.99
1.6
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
79
2.59
2.90
1.3
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
12
46
2.85
2.47
7.6
6.5
mmol/l
1.1
1.7
0.24
12
35
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
28
160
2.07
2.46
2.4
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
62
468
1.97
2.43
3.2
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
28
3.45
2.38
8.9
5.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
214
1.93
2.26
1.3
1.2
u/ml
0.6
1.6
1.03
11
57
(3007853) Bacteria identified in Skin by Aerobe culture
16
75
2.37
2.24
1.9
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
14
4.50
2.19
2.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
25
3.40
2.15
8.4
5.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
10
38
2.83
2.08
1.7
2.3
g/l
0.2
0.2
—
10
38
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
51
2.55
2.05
1.3
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
21
3.52
2.01
4.9
8.3
%
0.9
0.8
—
7
21
(3014007) Fractional oxyhemoglobin in Arterial blood
7
21
3.52
2.01
4.9
8.3
%
94.7
94.9
—
7
21
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
21
3.52
2.01
4.9
8.3
%
1.4
1.3
—
7
21
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
11
4.73
1.96
1.2
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
53
2.45
1.90
1.2
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
35
2.74
1.86
6.8
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
63
501
1.80
1.85
5.8
4.0
—
39.6
—
0
9
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
29
2.92
1.84
1.6
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
23
3.20
1.84
1.1
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
23
3.20
1.84
2.3
2.0
%
81.7
106.0
—
7
23
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
18
3.49
1.77
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
30
2.82
1.77
5.4
1.8
kpa
5.2
5.6
—
8
30
(3029937) Albumin [Presence] in Urine by Test strip
29
187
1.80
1.74
4.2
2.8
estimate
0.0
0.0
—
10
73
(3020891) Body temperature
5
13
4.00
1.74
4.2
4.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
5
13
4.00
1.74
3.8
4.7
mmol/l
1.7
1.0
—
5
13
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
154
1.85
1.73
5.8
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
66
539
1.77
1.70
5.7
3.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
19
3.30
1.69
6.0
1.4
mmol/l
24.3
24.8
—
6
19
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
32
2.64
1.64
1.1
1.2
—
15.4
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
32
2.64
1.64
1.4
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
12
57
2.27
1.63
1.5
1.3
u/ml
1078.9
101.7
0.61
12
49
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
20
3.13
1.61
10.7
8.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
33
2.55
1.58
2.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
51
2.31
1.57
1.4
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
35
245
1.69
1.56
5.3
5.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
33
228
1.69
1.54
2.9
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
15
3.46
1.54
1.0
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
32
220
1.69
1.52
5.1
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
22
2.84
1.46
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
22
2.84
1.46
1.3
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
22
2.84
1.46
2.3
2.5
%
155.7
141.2
—
6
22
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
23
2.72
1.39
6.0
4.0
mmol/l
24.0
25.0
—
6
23
(42529406) Shigella sp [Presence] in Stool by Culture
6
23
2.72
1.39
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
35
252
1.62
1.38
1.9
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
38
0.00
1.38
0.0
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
27
182
1.68
1.37
2.0
1.8
u/l
92.0
109.8
0.32
27
176
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
18
2.87
1.30
1.0
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
8
37
2.27
1.25
7.5
1.8
kpa
6.0
5.6
—
8
37
(3002032) Base excess in Venous blood by calculation
8
37
2.27
1.25
7.5
1.8
mmol/l
1.3
2.1
—
8
26
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
206
1.59
1.19
1.8
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
26
180
1.62
1.18
5.3
4.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
14
81
1.86
1.17
1.5
2.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
20
2.58
1.16
3.2
1.5
%
0.9
0.7
—
5
20
(3012544) pH of Venous blood
8
40
2.09
1.15
7.5
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
30
2.44
1.15
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
31
2.36
1.13
1.9
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
41
2.04
1.12
2.5
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
84
774
1.88
1.11
15.6
8.5
mmol/l
139.4
139.8
1.23
84
755
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
32
236
1.54
1.11
2.0
1.9
pmol/l
111.4
100.4
0.46
15
125
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
32
2.28
1.11
1.4
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
21
2.46
1.10
3.2
1.6
%
1.3
0.9
—
5
21
(3007164) IgA [Mass/volume] in Serum or Plasma
28
201
1.56
1.09
1.3
1.3
g/l
1.8
2.1
0.76
21
126
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
45
2.11
1.08
1.4
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
34
2.14
1.05
3.1
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
34
2.14
1.05
1.4
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
46
372
1.47
1.01
5.4
3.0
estimate
0.0
0.0
—
9
72
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
38
296
1.48
1.01
4.9
2.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
84
778
1.82
1.00
15.8
8.5
mmol/l
3.9
3.9
0.11
84
756
(3023511) Choriogonadotropin [Units/volume] in Urine
10
55
1.92
0.96
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
262
1.47
0.94
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
23
164
1.53
0.91
6.0
2.9
kg/l
1.0
1.0
—
5
21
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
29
2.14
0.91
1.0
1.7
g/l
0.2
0.2
—
6
29
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
113
0.50
0.90
1.3
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
80
733
1.65
0.88
12.5
7.9
ml/min/173m2
90.3
92.2
0.29
66
588
(3030467) Casts [#/volume] in Urine by Automated count
24
175
1.50
0.86
5.6
2.4
e6/l
0.1
0.2
0.36
18
122
(36304419) Bacteria [Presence] in Urine
25
184
1.49
0.86
4.0
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
31
2.00
0.86
1.2
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
31
2.00
0.86
7.5
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
16
106
1.62
0.86
5.8
2.2
e6/l
0.4
0.9
—
10
54
(3009261) Glucose [Presence] in Urine by Test strip
45
372
1.41
0.84
5.5
3.0
estimate
0.0
0.0
—
8
73
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
32
1.93
0.83
1.0
1.6
g/l
1.3
1.2
—
6
32
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
15
101
1.58
0.76
5.9
2.3
e6/l
3.1
4.0
—
9
50
(3034770) Mitochondria Ab [Titer] in Serum
5
24
2.14
0.76
1.0
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
24
2.14
0.76
1.2
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
207
1.43
0.75
7.2
7.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
162
1.47
0.75
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
44
368
1.37
0.74
7.9
4.5
estimate
0.0
0.0
—
10
73
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
25
2.05
0.74
4.4
1.8
g/l
115.8
139.4
—
5
25
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
27
1.90
0.69
1.4
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.90
0.69
1.4
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
70
1.65
0.69
1.6
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
62
1.69
0.68
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
28
1.83
0.67
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
29
1.76
0.65
2.0
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
29
1.76
0.65
1.0
1.1
—
—
—
0
0
(3015736) pH of Urine
36
298
1.34
0.63
5.8
2.7
—
—
—
0
0
(4010399)
8
50
1.66
0.63
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
51
1.62
0.62
1.3
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
72
1.60
0.62
3.6
3.3
pmol/l
4.5
4.7
0.42
11
66
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
30
1.70
0.62
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
25
197
1.37
0.59
5.4
2.4
e6/l
13.7
58.7
0.79
19
144
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5
88
0.54
0.59
2.2
1.8
nmol/l
329.2
388.3
—
5
83
(3000570) Elastase.pancreatic [Mass/mass] in Stool
0
23
0.00
0.59
0.0
1.2
—
380.9
—
0
8
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
38
1.62
0.55
1.2
1.5
pmol/l
57.8
46.1
—
6
38
(3008898) HLA-B27 [Presence]
9
64
1.45
0.53
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
143
0.66
0.53
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
65
1.43
0.52
7.0
4.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
249
1.30
0.51
1.9
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
48
1.49
0.48
3.4
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
78
1.47
0.45
1.0
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
29
244
1.27
0.44
6.1
3.1
e6/l
4.8
43.4
0.97
20
152
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
244
1.27
0.44
1.7
1.7
—
—
—
0
0
(3000492) Spirometry study
10
70
1.48
0.44
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
31
1.65
0.44
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
57
1.44
0.43
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
58
1.41
0.43
1.0
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
33
1.54
0.42
1.4
1.6
nmol/l
0.4
0.4
—
5
26
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
108
1.35
0.38
1.6
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
41
1.49
0.37
1.2
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
83
797
1.39
0.36
14.6
9.6
mg/l
17.5
18.4
0.11
70
588
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
82
1.39
0.36
1.4
1.3
iu/ml
294.2
150.8
—
6
36
(3009542) Hematocrit [Volume Fraction] of Blood
80
766
1.32
0.34
19.0
11.4
%
38.7
40.0
1.02
66
646
(3041096) Erythrocytes [Presence] in Urine by Automated
27
232
1.23
0.34
3.5
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
11
83
1.37
0.34
1.9
1.6
nmol/l
1120.1
1069.1
0.09
11
65
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
120
1.30
0.32
1.9
1.5
—
—
—
0
0
(3019225) pH of Specimen
7
55
1.29
0.31
4.0
4.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
73
695
1.23
0.30
3.8
4.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
122
1.27
0.29
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
75
1.22
0.26
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
13
106
1.26
0.25
1.5
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
91
0.75
0.24
3.1
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
93
0.73
0.23
1.4
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
12
0.00
0.21
0.0
4.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
3.7
—
19.5
—
0
13
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
185
1.17
0.20
1.8
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
62
1.14
0.18
1.9
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
66
0.74
0.17
2.2
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
88
0.78
0.15
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
38
360
1.09
0.11
2.2
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
31
329
0.91
0.11
3.0
2.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
5
45
1.12
0.10
9.6
3.7
—
0.0
—
0
12
(3025159) Blasts/100 leukocytes in Blood
5
47
1.07
0.09
9.6
3.5
—
0.0
—
0
10
(3002179) Metamyelocytes/100 leukocytes in Blood
5
48
1.04
0.09
9.6
3.4
—
0.6
—
0
9
(4035726)
6
53
1.14
0.09
1.7
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
107
1.14
0.09
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
56
1.08
0.09
1.7
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
83
1.09
0.07
2.4
2.2
—
23.3
—
0
5
(3013512) EKG study
17
159
1.08
0.05
2.8
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
124
1.06
0.01
1.3
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
98
1.02
0.00
1.3
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
113
0.97
0.00
1.7
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
207
1.02
0.00
2.0
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.4
—
0
5
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
27.5
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
64
0.93
0.00
1.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
371.6
—
0
5
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
64
0.93
0.00
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
5
0.00
0.00
0.0
1.0
—
1.3
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
142.7
—
0
6
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.3
—
3.9
—
0
8
(3017181) Myelocytes/100 leukocytes in Blood
5
49
1.02
0.00
9.6
3.5
—
0.7
—
0
13
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
56
0.89
0.00
1.8
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
65
0.92
0.00
1.7
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
10.2
—
0
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
155.7
—
0
6
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
1855.9
—
0
7
(3005033) Fetal Nuchal fold Thickness US
5
55
0.90
0.00
1.8
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
60
1.00
0.00
2.2
2.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
65
0.92
0.00
1.7
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.3
—
106.1
—
0
8
(40760888) Immunoglobulin light chains.free panel - Serum
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
70
1.00
0.00
1.7
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_ECLAMPSIA and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have O15_ECLAMPSIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: O15_ECLAMPSIA – Eclampsia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data